Quinazolinone derivatives useful as FGFR kinase modulators
US9493426B2 · kind B2 · utility
21Cited by
21References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2014 |
| Grant date | Nov 15, 2016 |
| Priority date | — |
| Expiry date | Apr 25, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new quinazolinone derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.